Učitavanje...
Preparation & in vitro evaluation of (90)Y-DOTA-rituximab
BACKGROUND & OBJECTIVES: Radioimmunotherapy is extensively being used for the treatment of non-Hodgkin's lymphoma (NHL). Use of rituximab, a chimeric anti-CD20 antibody directed against the CD20 antigen in combination with suitable beta emitters is expected to result in good treatment respo...
Spremljeno u:
| Izdano u: | Indian J Med Res |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Medknow Publications & Media Pvt Ltd
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4822370/ https://ncbi.nlm.nih.gov/pubmed/26997015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0971-5916.178593 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|